专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明申请

WO2012165861A3 SUBSTRATE PROCESSING SYSTEM AND SUBSTRATE PROCESSING METHOD USING THE SAME 审中-公开
标题翻译：基板处理系统和基板处理方法
公开(公告)号：WO2012165861A3
公开(公告)日：2013-04-04
申请号：PCT/KR2012004268
申请日：2012-05-30
申请人： TES CO LTD , JUNG JIN-OK , LEE SANG-SUN , HAN JUNG-MIN
发明人： JUNG JIN-OK , LEE SANG-SUN , HAN JUNG-MIN
IPC分类号： H01L21/302
CPC分类号： H01L21/02057 , H01L21/67028 , H01L21/67207
摘要： Provided are a substrate processing system with an improved structure which can prevent a damage from occurring in a lower layer and efficiently remove both etching byproducts and fumes, and a substrate processing method using the same. The substrate processing system includes a wet cleaning module configured to supply a cleaning solutionto a substrate to clean a surface of the substrate and dry the cleaned substrate, and a dry cleaning module configured to spray a cleaning gas containing HF gas to the substrate to etch a silicon oxide layer formed on the substrate.
摘要翻译：提供了一种具有改进的结构的基板处理系统，其可以防止在下层中发生损坏并有效地去除蚀刻副产物和烟雾，以及使用其的基板处理方法。衬底处理系统包括湿清洁模块，其被配置为将清洁溶液供应到衬底以清洁衬底的表面并干燥清洁的衬底;以及干洗模块，其被配置为将含有HF气体的清洁气体喷射到衬底以蚀刻形成在基板上的氧化硅层。

2. 发明申请

WO2010100764A1 COMPOSITE GRAPHITE PARTICLES AND LITHIUM SECONDARY BATTERY USING THE SAME 审中-公开
标题翻译：使用该复合石墨颗粒和锂二次电池
公开(公告)号：WO2010100764A1
公开(公告)日：2010-09-10
申请号：PCT/JP2009/054356
申请日：2009-03-02
申请人： SHOWA DENKO K.K. , LS MTRON Ltd. , SOTOWA, Chiaki , SUDOH, Akinori , TAKEUCHI, Masataka , HAN, Kyung-hee , HAN-Jung-min , OH, Jung-hun
发明人： SOTOWA, Chiaki , SUDOH, Akinori , TAKEUCHI, Masataka , HAN, Kyung-hee , HAN-Jung-min , OH, Jung-hun
IPC分类号： C01B31/04
CPC分类号： H01M4/587 , C01B32/20 , H01M4/133 , H01M4/1393 , H01M10/052
摘要： The present invention provides composite graphite particles, which are useful for a negative electrode in a secondary battery having high capacitance, good charge- discharge characteristics and good charge-discharge cycle characteristics; and a paste for negative electrode, a negative electrode and a lithium secondary battery which use the composite graphite particles. The composite graphite particles of the present invention comprises a core material consisting of graphite having a interlayer distance d(002) of 0.337 nm or less in which the intensity ratio I D /I G (R value) between the peak intensity (I D ) in a range of 1300 to 1400 cm -1 and the peak intensity ( I G ) in a range of 1580 to 1620 cm -1 as measured by Raman spectroscopy spectra is from 0.01 to 0.1 and a carbonaceous surface layer in which the intensity ratio I D /I G (R value) between the peak intensity (I D ) in a range of 1300 to 1400 cm -1 and the peak intensity ( I G ) in a range of 1580 to 1620 cm -1 as measured by Raman scattering spectroscopy is 0.2 or higher; wherein the peak intensity ratio I 110 /I 004 between the peak intensity (I 004 ) of face (110) and the peak intensity (I 004 ) of face (004) obtained by XRD measurement on the graphite crystal is 0.2 or higher when the particles are mixed with a binder and pressure-molded to a density of 1.55 to 1.65 g/cm 3 .
摘要翻译：本发明提供了复合石墨粒子，其可用于具有高电容，良好的充放电特性和良好的充放电循环特性的二次电池中的负极; 以及使用该复合石墨粒子的负极，负极和锂二次电池用糊料。本发明的复合石墨粒子包括由石墨构成的芯材，其中层间距离d（002）为0.337nm以下，其中峰强度（ID）在一定范围内的强度比ID / IG（R值）为1300〜1400cm -1，通过拉曼光谱测定的1580〜1620cm -1范围内的峰强度（IG）为0.01〜0.1，强度比ID / IG（R 通过拉曼散射光谱法测定的在1300〜1400cm -1范围内的峰强度（ID）与1580〜1620cm -1范围内的峰强度（IG）之差为0.2以上; 其中，当将所述颗粒与所述石墨晶体的XRD测量得到的在所述石墨晶体上通过XRD测量获得的面（110）的峰强度（I004）和所述面（004）的峰强度（I004）之间的峰强度比I110 / I004为0.2以上时，粘合剂，并以1.55-1.65g / cm3的密度进行压塑。

3. 发明申请

WO2010041892A3 NOVEL APPLICATION OF AIMP1 POLYPEPTIDE 审中-公开
标题翻译： AIMP1多肽的新应用
公开(公告)号：WO2010041892A3
公开(公告)日：2010-08-19
申请号：PCT/KR2009005778
申请日：2009-10-09
申请人： SNU R&DB FOUNDATION , KIM SUNGHOON , HAN JUNG MIN
发明人： KIM SUNGHOON , HAN JUNG MIN
IPC分类号： C07K16/18
CPC分类号： G01N33/564 , G01N2800/102
摘要： The present invention relates to a novel application of AIMP1 polypeptide and more specifically to a composition for diagnosis of rheumatoid arthritis including an antibody against AIMP1; a diagnostic kit including same; and a method for diagnosis of rheumatoid arthritis comprising a step wherein a specimen is obtained from an object and a step wherein the AIMP1 polypeptide included in said specimen is detected; and to an antibody against the AIMP1 polypeptide for the diagnosis of rheumatoid arthritis. The present invention provides a composition for diagnosis of rheumatoid arthritis as a novel diagnosis marker for rheumatoid arthritis, a diagnostic kit including the same and a method of rheumatoid arthritis diagnosis comprising a step wherein a specimen is obtained from a subject and a step wherein the AIMP1 polypeptide included in said specimen is detected; and the antibody against the AIMP1 polypeptide for the diagnosis of rheumatoid arthritis. The composition, diagnosis kit, diagnosis method and the antibody against the AIMP1 polypeptide of the present invention enable rheumatoid arthritis to be readily diagnosed from the specimen of a patient, and thus may be used for early diagnosis and confirmation of rheumatoid arthritis.
摘要翻译：本发明涉及AIMP1多肽的新应用，更具体地涉及用于诊断类风湿性关节炎的组合物，包括抗AIMP1抗体; 包括其的诊断试剂盒; 以及用于诊断类风湿性关节炎的方法，包括从物体获得样本的步骤和其中检测到包含在所述样本中的AIMP1多肽的步骤; 以及针对AIMP1多肽的抗体用于诊断类风湿性关节炎。本发明提供了一种用于诊断类风湿性关节炎的组合物，作为类风湿性关节炎的新型诊断标记物，包括其的诊断试剂盒和类风湿性关节炎诊断方法，其包括从受试者获得样品的步骤和其中AIMP1 检测包含在所述样品中的多肽; 和针对AIMP1多肽的抗体用于诊断类风湿性关节炎。本发明的组合物，诊断试剂盒，诊断方法和针对AIMP1多肽的抗体使得类风湿性关节炎能够从患者标本容易地诊断出来，因此可用于类风湿性关节炎的早期诊断和确认。

4. 发明申请

WO2007136205A1 MARKERS FOR DIAGNOSIS OF AUTOIMMUNE DISEASES AND METHOD FOR DIAGNOSIS USING THE SAME 审中-公开
标题翻译：用于诊断自身免疫性疾病的标记物及其诊断方法
公开(公告)号：WO2007136205A1
公开(公告)日：2007-11-29
申请号：PCT/KR2007/002444
申请日：2007-05-18
申请人： SEOUL NATIONAL UNIVERSITY INDUSTRY FOUNDATION , IMAGENE CO., LTD. , SONG, Young-Wook , KIM, Sung-Hoon , HAN, Jung-Min
发明人： SONG, Young-Wook , KIM, Sung-Hoon , HAN, Jung-Min
IPC分类号： C12Q1/68
CPC分类号： C12Q1/6883 , C12Q2600/156 , C12Q2600/158
摘要： The present invention relates to a marker for diagnosis of autoimmune diseases and a method for diagnosis of autoimmune diseases using the same, and more particularly to a marker for diagnosis of autoimmune diseases that is based on polymorphism of gp96, and a kit, a microarray and a method for diagnosis of autoimmune diseases using the same. The marker for diagnosis of autoimmune diseases according to the present invention and the kit, the microarray and the method for diagnosis of autoimmune diseases using the same may be useful to promptly and accurately diagnose the autoimmune diseases.
摘要翻译：本发明涉及用于诊断自身免疫性疾病的标记物和使用其的自身免疫性疾病的诊断方法，更具体地，涉及基于gp96多态性的自身免疫性疾病的诊断标记物，以及试剂盒，微阵列和用于使用其自身免疫性疾病的诊断方法。根据本发明的自身免疫性疾病的诊断标记以及使用该自身免疫性疾病的试剂盒，微阵列和诊断方法可用于及时准确地诊断自身免疫性疾病。

5. 发明申请

WO2004098468A1 A TRACTION APPARATUS FOR THE CERVICAL VERTEBRAE 审中-公开
标题翻译：一个用于维也纳的追踪装置
公开(公告)号：WO2004098468A1
公开(公告)日：2004-11-18
申请号：PCT/KR2004/001031
申请日：2004-05-03
申请人： HAN, Jung-Min
发明人： HAN, Jung-Min
IPC分类号： A61F5/042
CPC分类号： A61H1/0296 , A61F5/04 , A61H1/0218 , A61H2201/1607 , A61H2201/1616
摘要： A traction apparatus for cervical vertebrae for elongating the cervical vertebrae with the cervical vertebrae being stooped in response to the manipulation of a user. Force is only concentrated to the rear part of the neck, such that impact or pressure is not applied to the chin, thereby preventing TMJ disorder and further lengthening the elongation distance of the cervical vertebrae compared with elongating both the chin and rear part of the neck for effectively elongating the cervical vertebrae.
摘要翻译：用于使颈椎伸长的颈椎牵引装置响应于使用者的操纵而被弯曲。力仅集中在颈部的后部，使得下颚不施加冲击或压力，从而与延长颈部的下巴和后部相比，预防TMJ障碍并进一步延长颈椎的伸长距离用于有效延长颈椎。

6. 发明申请

WO2013043012A3 NOVEL USE OF LEUCYL TRNA SYNTHETASE 审中-公开
标题翻译： LEUCYL TRNA SYNTHETASE的新用途
公开(公告)号：WO2013043012A3
公开(公告)日：2013-05-16
申请号：PCT/KR2012007656
申请日：2012-09-24
申请人： MEDICINAL BIOCONVERGENCE RES CT , KIM SUNGHOON , HAN JUNG MIN
发明人： KIM SUNGHOON , HAN JUNG MIN
IPC分类号： G01N33/15 , C12N15/113 , C12N15/63
CPC分类号： G01N33/573 , C12N15/1137 , C12N2310/14 , C12Y601/01004 , G01N33/574 , G01N2800/044
摘要： The present invention relates to novel use of leucyl tRNA synthetase and more particularly it relates a method of screening an agent for preventing or treating mTORCl mediated diseases by screening an test agent which inhibits binding ability of LRS to RagD or RagD GTPases and a method of reducing cell size compared to the control group comprising inhibiting expression of intracellular LRS. The method of the present invention provides novel method of regulating cell size and further the screening method of screening can be used in developing novel reagent for treatment of disease such as cancer.
摘要翻译：本发明涉及亮氨酸tRNA合成酶的新用途，更具体地说，涉及通过筛选抑制LRS对RagD或RagD GTP酶的结合能力的测试剂来筛选药物以预防或治疗mTORC1介导的疾病的方法，以及减少细胞大小与包含抑制细胞内LRS表达的对照组相比。本发明的方法提供了调节细胞大小的新方法，进一步的筛选方法可用于开发用于治疗诸如癌症的疾病的新型试剂。

7. 发明申请

WO2013043012A2 NOVEL USE OF LEUCYL TRNA SYNTHETASE 审中-公开
标题翻译： LEUCYL TRNA SYNTHETASE的新用途
公开(公告)号：WO2013043012A2
公开(公告)日：2013-03-28
申请号：PCT/KR2012/007656
申请日：2012-09-24
申请人： MEDICINAL BIOCONVERGENCE RESEARCH CENTER , KIM, Sunghoon , HAN, Jung Min
发明人： KIM, Sunghoon , HAN, Jung Min
IPC分类号： G01N33/15 , C12N15/63 , C12N15/113
CPC分类号： G01N33/573 , C12N15/1137 , C12N2310/14 , C12Y601/01004 , G01N33/574 , G01N2800/044
摘要： The present invention relates to novel use of leucyl tRNA synthetase and more particularly it relates a method of screening an agent for preventing or treating mTORCl mediated diseases by screening an test agent which inhibits binding ability of LRS to RagD or RagD GTPases and a method of reducing cell size compared to the control group comprising inhibiting expression of intracellular LRS. The method of the present invention provides novel method of regulating cell size and further the screening method of screening can be used in developing novel reagent for treatment of disease such as cancer.
摘要翻译：本发明涉及亮氨酰tRNA合成酶的新用途，更具体地涉及筛选用于预防或治疗mTORC1介导的疾病的药剂的方法，其通过筛选抑制LRS与RagD的结合能力的测试药剂或RagD GTP酶以及与对照组相比降低细胞大小的方法，其包括抑制细胞内LRS的表达。本发明的方法提供了调节细胞大小的新方法，并且筛选的筛选方法可用于开发用于治疗诸如癌症的疾病的新型试剂。

8. 发明申请

WO2009136671A1 P53 REGULATORY PROTEIN AND USES THEREOF 审中-公开
标题翻译： P53调节蛋白及其用途
公开(公告)号：WO2009136671A1
公开(公告)日：2009-11-12
申请号：PCT/KR2008/002559
申请日：2008-05-07
申请人： SEOUL NATIONAL UNIVERSITY INDUSTRY FOUNDATION , KIM, Sunghoon , HAN, Jung Min
发明人： KIM, Sunghoon , HAN, Jung Min
IPC分类号： A61K39/395 , C07K1/00 , C12N15/12
CPC分类号： C07K14/4747
摘要： The present invention relates to a p53 regulatory protein and uses thereof. The present invention provides a method for modulating p53 in a cell or a tissue, and a method for identifying an agent modulating p53 activity using AIMP2 polypeptide or a nucleotide encoding the polypeptide. And the present invention provides a method for inhibiting ubiquitination of p53 and a method for identifying for an agent modulating an interaction between p53 and AIMP2.
摘要翻译：本发明涉及一种p53调节蛋白及其用途。本发明提供了调节细胞或组织中p53的方法，以及使用AIMP2多肽或编码该多肽的核苷酸鉴定调节p53活性的药剂的方法。本发明提供了抑制p53泛素化的方法以及用于鉴定调节p53和AIMP2之间相互作用的试剂的方法。

9. 发明申请

WO2008133359A1 METHOD FOR SCREENING IMMUNE MODULATOR 审中-公开
标题翻译：筛选免疫调节剂的方法
公开(公告)号：WO2008133359A1
公开(公告)日：2008-11-06
申请号：PCT/KR2007/002072
申请日：2007-04-27
申请人： IMAGENE CO., LTD. , KIM, Sung-Hoon , HAN, Jung-Min
发明人： KIM, Sung-Hoon , HAN, Jung-Min
IPC分类号： C12Q1/00 , C12Q1/68
CPC分类号： G01N33/66 , G01N33/574 , G01N2500/04 , G01N2800/24
摘要： Disclosed is a method for screening an immune modulator. More specifically, disclosed is a method of screening an immune modulator, an anticancer agent and an agent for treating autoimmune diseases, which regulate the cell surface expression level of gp96, using the binding of the region of amino acids 54-192 of AIMPl to the region of amino acids 699-799 of AIMPl, set forth in SEQ ID NO: 18. Also disclosed is a method of diagnosing autoimmune diseases using the binding.
摘要翻译：公开了一种筛选免疫调节剂的方法。更具体地，公开了使用AIMP1的氨基酸54-192的区域结合到免疫调节剂，抗癌剂和用于治疗自身免疫性疾病的药剂的方法，其调节gp96的细胞表面表达水平 AIMP1的氨基酸699-799的区域，如SEQ ID NO：18所示。还公开了使用结合来诊断自身免疫性疾病的方法。

10. 发明申请

WO2008094012A1 NOVEL POLYPEPTIDE HAVING ANTI-TUMOR ACTIVITY 审中-公开
标题翻译：具有抗肿瘤活性的新型多肽
公开(公告)号：WO2008094012A1
公开(公告)日：2008-08-07
申请号：PCT/KR2008/000621
申请日：2008-02-01
申请人： IMAGENE CO., LTD. , KIM, Sunghoon , HAN, Jung Min , PARK, Sang Gyu , LEE, Yoen Sook
发明人： KIM, Sunghoon , HAN, Jung Min , PARK, Sang Gyu , LEE, Yoen Sook
IPC分类号： C07K14/47 , C12N15/12
CPC分类号： C07K14/4747
摘要： The present invention relates to a novel polypeptide having ant i- tumor activity through inducing apoptosis of endothelial cell and use thereof. More particularly, the present invention relates to a method for inducing apoptosis of endothelial cell, and for preventing or treating cancer, comprising administering to a subject in need thereof an effective amount of (a) an isolated polypeptide having the amino acid sequence of SEQ ID NO: 9 or the amino acid sequence having at least 90% sequence homology to the amino acid sequence of SEQ ID NO: 9; or (b) an isolated polynucleotide encoding the polypeptide of (a).
摘要翻译：本发明涉及通过诱导内皮细胞凋亡及其用途而具有抗肿瘤活性的新型多肽。更具体地说，本发明涉及诱导内皮细胞凋亡和预防或治疗癌症的方法，包括向有需要的受试者施用有效量的（a）具有SEQ ID NO：1的氨基酸序列的分离多肽或与SEQ ID NO：9的氨基酸序列具有至少90％序列同源性的氨基酸序列; 或（b）编码（a）的多肽的分离的多核苷酸。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式